AIM2 and neoplasm: However, in colorectal cancer and prostate cancer, AIM2 acted as a tumour suppressor by supporting genomic stability via regulating DNA-PK (repairs breaks in dsDNA) and PI3K/Akt pathways (promotes proliferation and survival) [182,183].